Ellume, page-117

I am talking about people like you ranting that we need to get our share of Ellumes financial success. I am telling you that contracts will often include clauses to protect against such predatory and opportunistic behaviour come renewal. Ellume didn't want to invest in developing a product only to be left open to ADO holding an axe over their head come contract renewal. Ellume would have been negligent not to protect themselves from that.

And their success has clearly not been our success to-date. The quarterlies and Dereks commentary have confirmed that. Therefore, you have to assume we are using it as a loss-leader, OR we just don't feel we can sell Anteobind (yet) at a price that is going to provide any meaningful revenue on current volume.